THERIVA™ BIOLOGICS ANNOUNCES SALE OF SYN-004 (RIBAXAMASE) AND RELATED ANTIBIOTIC-DEGRADING ENZYME PORTFOLIO TO BIOSSIL LABS INC.

Reuters · 6d ago

Please log in to view news